6788 resources
By Version
By Authority
Package | Version | Identity | Name/Title | Status | Date | Auth | Source(s) |
---|---|---|---|---|---|---|---|
smart.who.int.refmart | R4 | COUNTRYISO2 ![]() | WHO RefMart ISO2 Country List | active | 2025-04 | who | internal |
smart.who.int.refmart | R4 | COUNTRYISO3 ![]() | WHO RefMart ISO3 Country List | active | 2025-04 | who | internal |
smart.who.int.refmart | R4 | COUNTRYM49 ![]() | WHO RefMart M49 Country List | active | 2025-04 | who | internal |
ihe.iti.mhd | R4 | DocumentReferenceStats ![]() | MHD DocumentReference status codes | active | 2025-04 | ihe | fhir |
ihe.iti.mhd | R4 | MHDlistTypesVS ![]() | MHD List Types ValueSet | active | 2025-04 | ihe | ihe |
ihe.iti.mhd | R4 | MHDprovideFolderActions ![]() | MHD Folder List Types ValueSet | active | 2025-04 | ihe | fhir |
ihe.iti.mhd | R4 | MHDprovidePatientActions ![]() | MHD Patient Types ValueSet | active | 2025-04 | ihe | fhir |
hl7.fhir.uv.cow | R4 | business-status ![]() | Clinical Orders Workflow Business Status Codes | active | 2025-05 | hl7 | fhir |
hl7.fhir.uv.cow | R4 | message-header-event ![]() | Clinical Orders Workflow - Message Header Event Codes | active | 2025-05 | hl7 | fhir |
hl7.fhir.uv.cow | R4 | order-notification-status-type ![]() | Order Notification Status Type | active | 2025-05 | hl7 | fhir |
jct.fhir.spenser | R5 | SpenserMedsVS ![]() | Spenser Medications - ValueSet | active | 2025-05 | internal | |
hl7.fhir.uv.cpg | R4 | anc-reason-for-visit-vs ![]() | ANC Reason for Visit ValueSet | active | 2024-11 | hl7 | fhir |
hl7.fhir.uv.cpg | R4 | cpg-active-condition-vs ![]() | CPG Active Condition Value Set | active | 2024-11 | hl7 | tho |
hl7.fhir.uv.cpg | R4 | cpg-activity-type-vs ![]() | CPG Activity Type Value Set | active | 2024-11 | hl7 | fhir |
hl7.fhir.uv.cpg | R4 | cpg-casefeature-pertinence-vs ![]() | CPG Case Feature Pertinence Value Set | active | 2024-11 | hl7 | fhir |
hl7.fhir.uv.cpg | R4 | cpg-casefeature-type-vs ![]() | CPG Case Feature Type Value Set | active | 2024-11 | hl7 | fhir |
hl7.fhir.uv.cpg | R4 | cpg-common-persona-vs ![]() | CPG Common Persona Value Set | active | 2024-11 | hl7 | fhir |
hl7.fhir.uv.cpg | R4 | cpg-common-process-vs ![]() | CPG Common Process Value Set | active | 2024-11 | hl7 | fhir |
hl7.fhir.uv.cpg | R4 | cpg-recommendation-direction-vs ![]() | CPG Recommendation Direction Value Set | active | 2024-11 | hl7 | fhir |
ihe.domain.profile | R4 | ihe-ToDo-laughing-positions ![]() | The positions during laughing | draft | 2025-03 | ihe | loinc |
hl7.fhir.uv.cmhaffr2 | R5 | change-info ![]() | Requirement Change Indicators | active | 2025-05 | hl7 | fhir |
hl7.fhir.uv.phd | R4 | ASN1attribute ![]() | ANS1ToHL7 codes defined for non-measurement attributes | active | 2018-09 | hl7 | fhir |
hl7.fhir.uv.phd | R4 | ASN1measurement ![]() | ANS1ToHL7 codes for measurement attributes | active | 2018-09 | hl7 | fhir |
hl7.fhir.uv.phd | R4 | CodeableConcept11073MDC ![]() | CodeableConcept 11073 Attributes | active | 2018-11 | hl7 | iso |
hl7.fhir.uv.phd | R4 | DeviceTypes11073MDC ![]() | MDC Device Specialization codes | active | 2021-09 | hl7 | iso |
hl7.fhir.uv.phd | R4 | MDCValueSet ![]() | MDC Value Set | active | 2025-04 | hl7 | iso |
hl7.fhir.uv.phd | R4 | MDCnotObject ![]() | MDC Non-Object codes | active | 2025-04 | hl7 | fhir |
hl7.fhir.uv.phd | R4 | MDCobject ![]() | MDC Object and Device nomenclature | active | 2025-04 | hl7 | iso |
hl7.fhir.uv.phd | R4 | Quantity11073MDC ![]() | Quantity 11073 Attributes | active | 2018-11 | hl7 | iso |
hl7.fhir.uv.phd | R4 | Range11073MDC ![]() | Range 11073 Attributes | active | 2018-11 | hl7 | iso |
hl7.fhir.uv.phd | R4 | SimpleAlertOperationalStates ![]() | Simple Alert Operational States | active | 2025-04 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-AAS ![]() | Aldosterone Antagonists Drug Value Set | draft | 2018-07 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-CYCS ![]() | Composite Cyclosporine Drug Value Set | draft | 2018-07 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-Hx-UGIB-snomed ![]() | Upper gastrointestinal bleed Value Set | draft | 2018-06 | hl7 | sct |
hl7.fhir.uv.pddi | R4 | valueset-LOOPDIURETIC ![]() | Loop Diuretic Drug Value Set | draft | 2018-08 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-NSAIDS ![]() | Nonsteroidal Anti-inflammatory Drugs Value Set | draft | 2018-07 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-PDDICDS-indicator ![]() | PDDI CDS indicator | active | 2025-03 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-PPIS ![]() | Proton Pump Inhibitor Drug Value Set | draft | 2018-06 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-SCS ![]() | Systemic Corticosteroid Drug Value Set | draft | 2018-07 | hl7 | fhir |
hl7.fhir.uv.pddi | R4 | valueset-aldosterone ![]() | Aldosterone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-aspirin ![]() | Aspirin Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-betamethasone-exclude ![]() | Exclude Betamethasone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-betamethasone ![]() | Betamethasone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-bromfenac-exclude ![]() | Exclude Bromfenac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-bromfenac ![]() | Bromfenac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-bumetanide ![]() | Bumetanide Medications Value Set | draft | 2022-11 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-calcium-LOINC ![]() | LOINC Codes for Serum Calcium | draft | 2018-08 | hl7 | loinc |
hl7.fhir.uv.pddi | R4 | valueset-celecoxib ![]() | Celecoxib Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-cloprednol ![]() | Cloprednol Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-cortisone ![]() | Cortisone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-cortivazol ![]() | Cortivazol Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-cyclosporine-exclude ![]() | Exclude cyclosporine Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-cyclosporine ![]() | Cyclosporine Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-deflazacort ![]() | Deflazacort Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-desoxycorticosterone ![]() | Desoxycorticosterone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-dexamethasone-exclude ![]() | Exclude Dexamethasone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-dexamethasone ![]() | Dexamethasone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-dexlansoprazole ![]() | Dexlansoprazole Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-diclofenac-exclude ![]() | Exclude Diclofenac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-diclofenac ![]() | Diclofenac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-diflunisal ![]() | Diflunisal Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-digoxin-LOINC ![]() | LOINC Codes for Digoxin Concentration | draft | 2018-08 | hl7 | loinc |
hl7.fhir.uv.pddi | R4 | valueset-digoxin ![]() | Digoxin Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-eplerenone ![]() | Eplerenone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-esomeprazole ![]() | Esomeprazole Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ethacrynate ![]() | Ethacrynate Medications Value Set | draft | 2022-11 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-etodolac ![]() | Etodolac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-fenoprofen ![]() | Fenoprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-fludrocortisone ![]() | Fludrocortisone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-fluocortolone-exclude ![]() | Exclude Fluocortolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-fluocortolone ![]() | Fluocortolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-flurbiprofen-exclude ![]() | Exclude Flurbiprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-flurbiprofen ![]() | Flurbiprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-furosemide ![]() | Furosemide Medications Value Set | draft | 2022-11 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-hydrocortisone-exclude ![]() | Exclude Hydrocortisone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-hydrocortisone ![]() | Hydrocortisone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ibuprofen-exclude ![]() | Exclude Ibuprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ibuprofen ![]() | Ibuprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-indomethacin ![]() | Indomethacin Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ketoprofen-exclude ![]() | Exclude Ketoprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ketoprofen ![]() | Ketoprofen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ketorolac-exclude ![]() | Exclude Ketorolac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-ketorolac ![]() | Ketorolac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-lansoprazole ![]() | Lansoprazole Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-magnesium-LOINC ![]() | LOINC Codes for Serum Potassium | draft | 2018-08 | hl7 | loinc |
hl7.fhir.uv.pddi | R4 | valueset-mefenamate ![]() | Mefenamate Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-meloxicam ![]() | Meloxicam Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-meprednisone ![]() | Meprednisone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-methylprednisolone-exclude ![]() | Exclude Methylprednisolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-methylprednisolone ![]() | Methylprednisolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-misoprostol ![]() | Misoprostol Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-nabumetone ![]() | Nabumetone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-naproxen ![]() | Naproxen Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-nepafenac-exclude ![]() | Exclude Nepafenac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-nepafenac ![]() | Nepafenac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-omeprazole ![]() | Omeprazole Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-oxaprozin ![]() | Oxaprozin Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-pantoprazole ![]() | Pantoprazole Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-paramethasone ![]() | Paramethasone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-piroxicam-exclude ![]() | Exclude Piroxicam Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-piroxicam ![]() | Piroxicam Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-potassium-LOINC ![]() | LOINC Codes for Serum Potassium | draft | 2018-08 | hl7 | loinc |
hl7.fhir.uv.pddi | R4 | valueset-prednisolone-exclude ![]() | Exclude Prednisolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-prednisolone ![]() | Prednisolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-prednisone ![]() | Prednisone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-prednylidene ![]() | Prednylidene Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-rabeprazole ![]() | Rabeprazole Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-renal-LOINC ![]() | LOINC Codes for Renal Function | draft | 2018-08 | hl7 | loinc |
hl7.fhir.uv.pddi | R4 | valueset-rimexolone-exclude ![]() | Exclude Rimexolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-rimexolone ![]() | Rimexolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-spironolactone ![]() | Spironolactone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-sulindac ![]() | Sulindac Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-tolmetin ![]() | Tolmetin Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-topicaldiclofenac ![]() | Topical Diclofenac Medications Value Set | draft | 2022-11 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-torsemide ![]() | Torsemide Medications Value Set | draft | 2022-11 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-triamcinolone-exclude ![]() | Exclude Triamcinolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-triamcinolone ![]() | Triamcinolone Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-trilostane ![]() | Trilostane Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.pddi | R4 | valueset-warfarin ![]() | Warfarin Medications Value Set | draft | 2018-07 | hl7 | rx |
hl7.fhir.uv.molecular-definition-data-types | R6 | molecular-definition-focus-vs ![]() | Surgical Procedure Value Set | draft | 2025-05 | hl7 | fhir |
ihe.pcc.aps | R4 | Advance.Directives.VS ![]() | Advance Directives | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Alcohol.USe.Frequency.VS ![]() | Alcohol USe Frequency | draft | 2023-10 | ihe | ucum |
ihe.pcc.aps | R4 | Antepartum.Education.VS ![]() | Antepartum Education | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Antepartum.Family.History.and.Genetic.Screening.VS ![]() | Antepartum Family History and Genetic Screening | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Antepartum.History.of.Infection.VS ![]() | Antepartum History of Infection | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Antepartum.History.of.Past.Illness.VS ![]() | Antepartum History of Past Illness | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Antepartum.Laboratory.VS ![]() | Antepartum Laboratory | draft | 2023-10 | ihe | loinc |
ihe.pcc.aps | R4 | Antepartum.Review.of.Systems.Menstrual.History.VS ![]() | Antepartum Review of Systems Menstrual History | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Smoking.Status.VS ![]() | Smoking Status | draft | 2023-10 | ihe | sct |
ihe.pcc.aps | R4 | Smoking.Tabbacco.Use.Frequency.VS ![]() | Smoking Tabbacco Use Frequency | draft | 2023-10 | ihe | ucum |
hl7.fhir.uv.phr | R4 | pcd-sleep-observation-code ![]() | Patient contributed data: sleep observation code | active | 2025-04 | hl7 | sct loinc |
hl7.fhir.uv.phr | R4 | pcd-sleep-observation-value ![]() | Patient contributed data: sleep stage value | active | 2025-04 | hl7 | sct |
who.fhir.anc-cds | R4 | anc-a-de13 ![]() | Co-habitants | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-a-de14 ![]() | Co-habitants Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-activity-codes ![]() | ANC Activity Codes | active | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de1 ![]() | Counselling on Caffeine Reduction | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de10 ![]() | Counselling on Second-Hand Smoke | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de102 ![]() | Type of vitamin A supplement dosage provided Choices | draft | 2025-03 | who | ucum |
who.fhir.anc-cds | R4 | anc-b10-de104 ![]() | Vitamin A supplementation not provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de105 ![]() | Vitamin A supplementation not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de108 ![]() | Reason calcium not prescribed | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de109 ![]() | Reason calcium not prescribed Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de113 ![]() | Risk of pre-eclampsia | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de114 ![]() | Pre-eclampsia risk counselling provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de116 ![]() | Reason aspirin not prescribed | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de117 ![]() | Reason aspirin not prescribed Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de121 ![]() | Risk of gestational diabetes mellitus (GDM) | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de124 ![]() | Gestational diabetes mellitus (GDM) risk counselling conducted | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de125 ![]() | Counselling conducted on HIV risk | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de126 ![]() | PrEP for HIV prevention provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de127 ![]() | Reason PrEP for HIV prevention was not provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de128 ![]() | Reason PrEP for HIV prevention was not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de13 ![]() | Counselling on Condom Use | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de133 ![]() | Counselling conducted on seeking care when danger signs occur | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de134 ![]() | Counsel to immediately go to the hospital if severe danger signs are present | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de135 ![]() | Counselling on ANC contact schedule conducted | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de136 ![]() | Counselling conducted on birth preparedness and complications readiness | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de137-choices-grouper ![]() | Planned birth place Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de137 ![]() | Planned birth place | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de138 ![]() | Planned birth place Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de14 ![]() | Counselling on Condom Use | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de140 ![]() | Planned birth place - Home Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de142 ![]() | Counselling conducted on Rh factor negative | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de143 ![]() | Counselling conducted on intrapartum antibiotic to prevent early neonatal Group B Streptococcus (GBS) infection | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de144 ![]() | Counselling on postpartum family planning conducted | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de145-choices-grouper ![]() | Family planning method selected Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de145 ![]() | Family planning method selected | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de146 ![]() | Family planning method selected - Copper-bearing intrauterine device (Cu-IUD) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de147 ![]() | Family planning method selected - Levonorgestrel intrauterine device (LNG-IUD) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de148 ![]() | Family planning method selected Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de162 ![]() | Family planning method selected - Female sterilization Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de164 ![]() | Counselling conducted on breastfeeding | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de165 ![]() | Tetanus toxoid (TT) 1 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de167 ![]() | Tetanus toxoid (TT) 2 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de169 ![]() | Tetanus toxoid (TT) 3 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de17 ![]() | Counselling on Alcohol Substance Abuse | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de171 ![]() | Tetanus toxoid (TT) 4 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de173 ![]() | Tetanus toxoid (TT) 5 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de175 ![]() | Reason tetanus toxoid (TT) vaccination not provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de176 ![]() | Reason tetanus toxoid (TT) vaccination not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de18 ![]() | Counselling on Alcohol Substance Abuse | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de181 ![]() | Counselling conducted on Hep B negative | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de182 ![]() | Hepatitis B-1 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de184 ![]() | Hepatitis B-2 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de186 ![]() | Hepatitis B-3 immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de188 ![]() | No doses of hepatitis B | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de189 ![]() | Reason Hep B vaccination not provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de190 ![]() | Reason Hep B vaccination not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de195 ![]() | Flu immunization provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de197 ![]() | Reason flu vaccine not provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de198 ![]() | Reason flu vaccine not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de2 ![]() | Counselling on Caffeine Reduction | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de203 ![]() | IPV first-line support provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de204 ![]() | Reason IPV first line support not done | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de205 ![]() | Reason IPV first line support not done Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de21 ![]() | Counselling on Non-Pharma Measures to Relieve Nausea and Vomiting | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de210 ![]() | What additional type of care provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de211 ![]() | What additional type of care provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de216 ![]() | Safety assessement | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de217 ![]() | Has the physical violence happened more often or gotten worse over the past 6 months | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de218 ![]() | Has he ever used a weapon or threatened you with a weapon | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de219 ![]() | Has he ever tried to strangle you | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de22 ![]() | Counselling on Non-Pharma Measures to Relieve Nausea and Vomiting | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de220 ![]() | Has he ever beaten you when you were pregnant | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de221 ![]() | Is he violently and constantly jealous of you | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de222 ![]() | Do you believe he could kill you | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de223 ![]() | Referrals made as part of first-line support and care | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de224 ![]() | Was client referred | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de225 ![]() | Was client referred Choices | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de233 ![]() | Preventive antihelminthic treatment provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de234 ![]() | Preventive antihelminthic treatment provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de237 ![]() | Reason no preventative treatment provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de238 ![]() | Reason no preventative treatment provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de241 ![]() | Counselling conducted on malaria prevention | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b10-de242 ![]() | Counselling conducted on malaria prevention | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de245 ![]() | IPTp-SP dose 1 provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de247 ![]() | IPTp-SP dose 2 provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de249 ![]() | IPTp-SP dose 3 provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de25 ![]() | Counselling on Pharmacological Measures to Relieve Nausea and Vomiting | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de251 ![]() | Malaria Prophylaxis | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de252 ![]() | Reason malaria prophylaxis not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de256 ![]() | Referral to Hospital | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de257 ![]() | Referral to Hospital | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de258 ![]() | Reason referral not done Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de26 ![]() | Counselling on Pharmacological Measures to Relieve Nausea and Vomiting | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de29 ![]() | Counselling on Diet and Lifestyle Changes to Prevent and Relieve Heartburn | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de3 ![]() | Procedure Not Done Reason Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de30 ![]() | Counselling on Diet and Lifestyle Changes to Prevent and Relieve Heartburn | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de33 ![]() | Counselling on Antacid Preparations to Relieve Heartburn | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de34 ![]() | Counselling on Antacid Preparations to Relieve Heartburn | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de37 ![]() | Counselling on Non-Pharmacological Treatment for Relief of Leg Cramps | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de38 ![]() | Counselling on Non-Pharmacological Treatment for Relief of Leg Cramps | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de41 ![]() | Counselling on Use of Magnesium-and Calcium to Relieve Leg Cramps | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de42 ![]() | Counselling on Use of Magnesium-and Calcium to Relieve Leg Cramps | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de45 ![]() | Counselling on Dietary Modifications to Relieve Constipation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de46 ![]() | Counselling on Dietary Modifications to Relieve Constipation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de49 ![]() | Counselling on Use of Wheat Bran or Other Fibre Supplements to Relieve Constipation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de5 ![]() | Counselling on Tobacco Cessation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de50 ![]() | Counselling on Use of Wheat Bran or Other Fibre Supplements to Relieve Constipation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de53 ![]() | Counselling on Regular Exercise Physiotherapy Support Belts and Acupuncture to Relieve Low Back and Pelvic Pain | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de54 ![]() | Counselling on Regular Exercise Physiotherapy Support Belts and Acupuncture to Relieve Low Back and Pelvic Pain | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de57 ![]() | Counselling on Non-Pharmacological Options for Varicose Veins and Oedema | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de58 ![]() | Counselling on Non-Pharmacological Options for Varicose Veins and Oedema | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de6 ![]() | Counselling on Tobacco Cessation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de61 ![]() | Counselling on Healthy Eating and Keeping Physically Active | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de62 ![]() | Counselling on Healthy Eating and Keeping Physically Active | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de65 ![]() | Counselling on Increasing Daily Energy Protein Intake | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de66 ![]() | Counselling on Increasing Daily Energy Protein Intake | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de69 ![]() | Counselling on Balanced Energy and Protein Dietary Supplementation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de70 ![]() | Counselling on Balanced Energy and Protein Dietary Supplementation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de73 ![]() | Hypertension | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de74 ![]() | Severe hypertension | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de75 ![]() | Pre-eclampsia | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de76 ![]() | Severe pre-eclampsia | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de77 ![]() | Counselling conducted on hypertension | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de78 ![]() | Counselling conducted on HIV positive | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de79 ![]() | Counselling conducted on hepatitis B positive | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de80 ![]() | Counselling conducted on hepatitis C positive | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de81 ![]() | Syphilis counselling and treatment | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de82 ![]() | Syphilis counselling, treatment and further testing | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de83 ![]() | Seven-day antibiotic regimen for asymptomatic bacteriuria (ASB) provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de84 ![]() | Reason seven-day antibiotic regimen for asymptomatic bacteriuria (ASB) not provided | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de85 ![]() | Reason seven-day antibiotic regimen for asymptomatic bacteriuria (ASB) not provided Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de87 ![]() | Counselling conducted on TB screening positive | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de88 ![]() | Counselling conducted on gestational diabetes mellitus (GDM) | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de89 ![]() | Counselling conducted on diabetes mellitus (DM) | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de9 ![]() | Counselling on Second-Hand Smoke | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de93 ![]() | Type of iron supplement dosage provided Choices | draft | 2025-03 | who | ucum |
who.fhir.anc-cds | R4 | anc-b10-de96 ![]() | Reason iron and folic acid not prescribed | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b10-de97 ![]() | Reason iron and folic acid not prescribed Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b4-de1 ![]() | Pregnancy confirmed | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de1-choices-grouper ![]() | Reason for coming to facility Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de1 ![]() | Reason for coming to facility | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de2 ![]() | First Antenatal Care Contact Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de3 ![]() | Scheduled Antenatal Care Contact Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de4 ![]() | Reason for coming to facility Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de48-choices-grouper ![]() | Danger signs Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de48 ![]() | Danger signs | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de49 ![]() | Danger Signs - No danger signs Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de5 ![]() | Specific health concern(s) | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de50 ![]() | Danger signs Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de51 ![]() | Danger Signs - Central cyanosis Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b5-de6 ![]() | Specific health concern(s) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de1 ![]() | Highest level of education achieved | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de100-choices-grouper ![]() | Tetanus toxoid-containing vaccine (TTCV) immunization history Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de100 ![]() | Tetanus toxoid-containing vaccine (TTCV) immunization history | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de101 ![]() | Tetanus toxoid-containing vaccine (TTCV) immunization history - Fully Immunized Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de102 ![]() | Tetanus toxoid-containing vaccine (TTCV) immunization history - Under Immunized Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de103 ![]() | Tetanus toxoid-containing vaccine (TTCV) immunization history - No Doses Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de104 ![]() | Tetanus toxoid-containing vaccine (TTCV) immunization history - Unknown Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de105-choices-grouper ![]() | Flu immunization history Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de105 ![]() | Flu immunization history | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de106 ![]() | Flu Immunization History - Fully Immunized Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de107 ![]() | Flu Immunization History - No Doses Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de108 ![]() | Flu Immunization History - Unknown Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de109-choices-grouper ![]() | Current medications Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de109 ![]() | Current medications | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de11 ![]() | Occupation - Employment that puts woman at increased risk for HIV (e.g. sex worker) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de110 ![]() | Current medications Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de12 ![]() | Occupation - Informal employment (other) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de125 ![]() | Current Medications - Co-trimoxazole Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de139-choices-grouper ![]() | Daily caffeine intake Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de139 ![]() | Daily caffeine intake | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de14 ![]() | Last menstrual period (LMP) date | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de140 ![]() | Daily caffeine intake - More than 2 cups of coffee Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de141 ![]() | Daily caffeine intake - More than 4 cups of tea Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de142 ![]() | Daily caffeine intake - More than 12 bars of chocolate Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de143 ![]() | Daily caffeine intake - More than one can of soda or energy drink Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de144 ![]() | Daily caffeine intake - None of the above daily caffeine intake Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de145 ![]() | Clinical enquiry for alcohol and other substance use done | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de146-choices-grouper ![]() | Current alcohol and/or other substance use Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de146 ![]() | Current alcohol and/or other substance use | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de147 ![]() | Current alcohol and/or other substance use - None Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de148 ![]() | Current alcohol and/or other substance use - Alcohol Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de149 ![]() | Current alcohol and/or other substance use - Cocaine Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de15 ![]() | Ultrasound done | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de150 ![]() | Current alcohol and/or other substance use - Injectable drugs Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de151 ![]() | Current alcohol and/or other substance use - Marijuana Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de152 ![]() | Current alcohol and/or other substance use - Other (specify) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de153 ![]() | Tobacco use | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de154 ![]() | Recently quit tobacco products | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de155 ![]() | Exposure to second-hand smoke | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de156-choices-grouper ![]() | Partner HIV status (reported) Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de156 ![]() | Partner HIV status (reported) | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de157 ![]() | Partner HIV status (reported) - HIV Positive Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de158 ![]() | Partner HIV status (reported) - HIV Negative Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de159 ![]() | Partner HIV status (reported) - Inconclusive Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de160 ![]() | Contraceptive use of male condoms | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de161 ![]() | Contraceptive use of female condoms | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de17 ![]() | Gestational age | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de18 ![]() | Source of gestational age | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de19 ![]() | Source of gestational age Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de2 ![]() | Highest level of education achieved Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de22 ![]() | Expected date of delivery (EDD) | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b6-de24 ![]() | Number of pregnancies (gravida) | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de25 ![]() | Number of miscarriages and/or abortions | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b6-de26 ![]() | Number of live births | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b6-de27 ![]() | Whether last live birth was preterm | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de28 ![]() | Whether last live birth was preterm Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de31 ![]() | Number of stillbirths | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de32 ![]() | Parity | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de33 ![]() | Number of caesarian sections | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de34-choices-grouper ![]() | Past pregnancy complications Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de34 ![]() | Past pregnancy complications | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de35 ![]() | Past pregnancy complications Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de37 ![]() | Past pregnancy complications - Pre-eclampsia Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de38 ![]() | Past pregnancy complications - Eclampsia Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de41 ![]() | Past pregnancy complications - Convulsions Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de42 ![]() | Past pregnancy complications - Forceps Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de43 ![]() | Past pregnancy complications - Gestational diabetes mellitus Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de44 ![]() | Past pregnancy complications - Heavy bleeding (during or after delivery) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de45 ![]() | Past pregnancy complications - Macrosomia Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de46 ![]() | Past pregnancy complications - Perineal tear (3rd or 4th degree) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de51 ![]() | Substance use during past pregnancy specification | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de53 ![]() | Substance use during past pregnancy specification Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de57 ![]() | Allergies | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de58 ![]() | Allergies Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de7-choices-grouper ![]() | Occupation Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de7 ![]() | Occupation | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de72 ![]() | Past surgeries | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de73 ![]() | Past surgeries Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de8 ![]() | Occupation Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de83-choices-grouper ![]() | Existing chronic health conditions Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de83 ![]() | Existing chronic health conditions | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de84 ![]() | Existing chronic health conditions - None Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de85 ![]() | Existing chronic health conditions Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de86 ![]() | Existing chronic health conditions - Autoimmune disease Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de90 ![]() | Existing chronic health conditions - Diabetes arising in pregnancy (gestational diabetes) Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de91 ![]() | Existing chronic health conditions - Diabetes, other or unspecified Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de92 ![]() | Existing chronic health conditions - Diabetes, pre-existing type 1 Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de93 ![]() | Existing chronic health conditions - Diabetes, pre-existing type 2 Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de96 ![]() | Existing chronic health conditions - Hypertension Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de97 ![]() | Existing chronic health conditions - Kidney disease Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b6-de99 ![]() | HIV diagnosis date | draft | 2025-03 | who | |
who.fhir.anc-cds | R4 | anc-b7-de-99 ![]() | Fetal movement Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de1-choices-grouper ![]() | Medication follow-up Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de1 ![]() | Medication follow-up | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de10 ![]() | Persistent behaviours - High caffeine intake Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de11 ![]() | Persistent behaviours - Tobacco use Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de12 ![]() | Persistent behaviours - Recently quit tobacco products Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de13 ![]() | Persistent behaviours - Exposure to second-hand smoke Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de14 ![]() | Persistent behaviours - No condom use during sex Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de15 ![]() | Persistent behaviours - Alcohol use Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de16 ![]() | Persistent behaviours - Substance use Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de17 ![]() | Persistent behaviours - No persistent behaviours Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de18-choices-grouper ![]() | Persistent physiological symptoms Choices Grouper | draft | 2021-09 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de18 ![]() | Persistent physiological symptoms | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de19 ![]() | Persistent physiological symptoms - None Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de2 ![]() | Medication follow-up Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de20 ![]() | Persistent physiological symptoms - Abnormal vaginal discharge Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de21 ![]() | Persistent physiological symptoms - Breathing difficulty Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de22 ![]() | Persistent physiological symptoms - Breathless routine activities Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de23 ![]() | Persistent physiological symptoms - Constipation Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de24 ![]() | Persistent physiological symptoms - Contractions Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de25 ![]() | Persistent physiological symptoms - Cough lasting more than 3 weeks Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de26 ![]() | Persistent physiological symptoms - Fever Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de27 ![]() | Persistent physiological symptoms - Gets tired easily Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de28 ![]() | Persistent physiological symptoms - Headache Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de29 ![]() | Persistent physiological symptoms - Heartburn Choices | draft | 2025-03 | who | internal |
who.fhir.anc-cds | R4 | anc-b7-de30 ![]() | Persistent physiological symptoms - Leg cramps Choices | draft | 2025-03 | who | internal |
XIG built as of 30 May 2025. Found 73338 resources in 1215 packages.